These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4135417)

  • 1. Evidence for virus-specific transplantation antigen in cells of lymphoid neoplasms induced by papovavirus SV40.
    Tevethia SS
    Int J Cancer; 1974 Apr; 13(4):494-9. PubMed ID: 4135417
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells.
    Tevethia SS; Butel JS
    Intervirology; 1973; 2(3):200-5. PubMed ID: 4366480
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40.
    Diamandopoulos GT
    Science; 1972 Apr; 176(4031):173-5. PubMed ID: 4335386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40.
    Tevethia SS; Tevethia MJ
    Prog Med Virol; 1975; 21():103-17. PubMed ID: 174151
    [No Abstract]   [Full Text] [Related]  

  • 6. Papovavirus SV40 transplantation immunity conferred by an adenovirus-SV40 hybrid.
    Rapp F; Tevethia SS; Melnick JL
    J Natl Cancer Inst; 1966 Apr; 36(4):703-8. PubMed ID: 4286938
    [No Abstract]   [Full Text] [Related]  

  • 7. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immune response to a drug-treated L5178Y lymphoma subline.
    Nicolin A; Bini A; Coronetti E; Goldin A
    Nature; 1974 Oct; 251(5476):654-5. PubMed ID: 4138894
    [No Abstract]   [Full Text] [Related]  

  • 9. The tumor imprint technique for demonstrating SV40 T antigen by immunofluorescence.
    Diamandopoulos GT; McLane MF
    Proc Soc Exp Biol Med; 1972 Oct; 141(1):62-6. PubMed ID: 4343196
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 11. Histocompatibility systems and disease states with particular reference to cancer.
    Walford RL; Smith GS; Waters H
    Transplant Rev; 1971; 7():78-111. PubMed ID: 4111979
    [No Abstract]   [Full Text] [Related]  

  • 12. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
    Blasecki JW; Tevethia SS
    Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of human papovavirus T antigens.
    Dougherty RM
    J Gen Virol; 1976 Oct; 33(1):61-70. PubMed ID: 62024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INDUCTION BY VIRUSES OF MALIGNANCIES IN ANIMALS.
    EDDY BE
    Health Lab Sci; 1964 Apr; 1():84-95. PubMed ID: 14166691
    [No Abstract]   [Full Text] [Related]  

  • 15. SV40 virus-induced tumour specific transplantation antigen in cultured mouse cells.
    Smith RW; Morganroth J; Mora PT
    Nature; 1970 Jul; 227(5254):141-5. PubMed ID: 4316952
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour specific transplantation antigen in hamster tumour cells induced with BK virus.
    Karjalainen HE; Laaksonen AM; Mäntyjärvi RA
    J Gen Virol; 1978 Oct; 41(1):171-4. PubMed ID: 212516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and partial purification of normal and tumor associated transplantation antigens of Rauscher leukemia cells.
    Martyré MC; Halle-Pannenko O; Jollès P
    Eur J Cancer (1965); 1973 Oct; 9(10):757-61. PubMed ID: 4803219
    [No Abstract]   [Full Text] [Related]  

  • 19. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S; Huet C; Tournier P
    Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). II. Association of SV40-TSTA activity with liposomes containing VSV glycolipids.
    Huet C; Ansel S
    Int J Cancer; 1977 Jul; 20(1):61-6. PubMed ID: 71275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.